Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering

Journal of Tissue Engineering and Regenerative Medicine

Volumn 3, Issue 5, 2009, Pages 398-404

  Wang, Limin ^a   Singh, Milind ^b   Bonewald, Lynda F ^c   Detamore, Michael S ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Rice University   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d University of Kansas   (United States)

Author keywords

IGF 1; Osteogenesis; Stem cells; Umbilical cord stroma

Indexed keywords

BONE; CALCIUM; CELL ENGINEERING; CELL PROLIFERATION; CELL SIGNALING; GENE EXPRESSION; LACTIC ACID; SCAFFOLDS (BIOLOGY);

HUMAN UMBILICAL CORD; INSULIN-LIKE GROWTH FACTOR-1; MESENCHYMAL STROMAL CELLS; MINERALISATION; OSTEOGENESIS; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC MEDIA; STEM-CELL; UMBILICAL CORD STROMA; UMBILICAL CORDS;

STEM CELLS;

BIOMATERIAL; CALCIUM; OSTEOCALCIN; POLYLACTIC ACID; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2; LACTIC ACID; POLYMER;

ARTICLE; BONE DEVELOPMENT; BONE TISSUE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; GERM LAYER; HISTOLOGY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; REGULATORY MECHANISM; TISSUE ENGINEERING; UMBILICAL CORD; UPREGULATION; BONE; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; METABOLISM; METHODOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION; STEM CELL; STROMA CELL; UMBILICAL VEIN;

BONE AND BONES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LACTIC ACID; MESENCHYMAL STEM CELLS; OSTEOGENESIS; POLYMERS; SIGNAL TRANSDUCTION; STEM CELLS; STROMAL CELLS; TISSUE ENGINEERING; UMBILICAL VEINS;

EID: 70449469349     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.176     Document Type: Article

References (48)

1. Atmani H, Chappard D, Basle MF. 2003; Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol. J Cell Biochem 89: 364-372.
2. Baksh D, Yao R, Tuan RS. 2007; Comparison of proliferative and multilineage differentiation potential of humanmesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25: 1384-1392.
3. Beresford JN, Joyner CJ, Devlin C, Triffitt JT. 1994; The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 39: 941-947.
4. Campard D, Lysy PA, Najimi M, Sokal EM. 2008; Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 134: 833-848.
5. Campbell MJ, Reddy GS, Koeffler HP. 1997; Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. J Cell Biochem 66: 413-425.
6. Can A, Karahuseyinoglu S. 2007; Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 25: 2886-2895.
7. Chen TL. 2004; Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone 35: 83-95.
8. Ducy P, Zhang R, Geoffroy V, et al. 1997; Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
9. Fu YS, Cheng YC, Lin MY, et al. 2006; Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24: 115-124.
10. Honsawek S, Dhitiseith D, Phupong V. 2006; Effects of demineralized bone matrix on proliferation and osteogenic differentiation of mesenchymal stem cells from human umbilical cord. J Med Assoc Thai 89(suppl 3): S189-195.
11. Hurrell S, Cameron RE. 2001; Polyglycolide: degradation and drug release. Part I: changes inmorphology during degradation. JMater Sci Mater Med 12: 811-816.
12. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997; Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
13. Jeong WK, Park SW, Im GI. 2008; Growth factors reduce the suppression of proliferation and osteogenic differentiation by titanium particles on MSCs. J Biomed Mater Res A 86A: 1137-1144.
14. Jomura S, Uy M, Mitchell K, et al. 2007; Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells. Stem Cells 25: 98-106.
15. Karahuseyinoglu S, Cinar O, Kilic E, et al. 2007; Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25: 319-331.
16. Kasukawa Y, Miyakoshi N, Mohan S. 2004; The anabolic effects of GH/IGF system on bone. Curr Pharm Des 10: 2577-2592.
17. Kim HJ, Zhao H, Kitaura H, et al. 2006; Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 116: 2152-2160.
18. Koch H, Jadlowiec JA, Campbell PG. 2005; Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 14: 621-631.
19. Komori T, Yagi H, Nomura S, et al. 1997; Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
20. Landis WJ. 1999; An overview of vertebrate mineralization with emphasis on collagen-mineral interaction. Gravit Space Biol Bull 12: 15-26.
21. Lee SY, Miwa M, Sakai Y, et al. 2007; In vitro multipotentiality and characterization of human unfractured traumatic hemarthrosisderived progenitor cells: a potential cell source for tissue repair. J Cell Physiol 210: 561-566.
22. Linkhart TA, Mohan S, Baylink DJ. 1996; Growth factors for bone growth and repair: IGF, TGFβ and BMP. Bone 19: S 1-12.
23. Livak KJ, Schmittgen TD. 2001; Analysis of relative gene expression data using real-time quantitative PCR and the 2[-ΔΔC(T)] method. Methods 25: 402-408.
24. Lund RD, Wang S, Lu B, et al. 2007; Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 25: 602-611.
25. Lu LL, Liu YJ, Yang SG, et al. 2006; Isolation and characterization of human umbilical cord mesenchymal stem cells with haematopoiesis-supportive function and other potentials. Haematologica 91: 1017-1026.
26. Marcacci M, Kon E,Moukhachev V, et al. 2007; Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13: 947-955.
27. Martin JA, Hamilton BE, Sutton PD, et al. 2007; Births: final data for 2005. Natl Vital Statist Rep 56: 1.
28. Meinel L, Karageorgiou V, Fajardo R, et al. 2004; Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 32: 112-122.
29. Mueller SM, Glowacki J. 2001; Age-related decline in the osteogenic potential of human bone marrow cells cultured in threedimensional collagen sponges. J Cell Biochem 82: 583-590.
30. Murata H, Tanaka H, Taguchi T, et al. 2004; Dexamethasone induces human spinal ligament derived cells toward osteogenic differentiation. J Cell Biochem 92: 715-722.
31. Partridge NC, Frampton RJ, Eisman JA, et al. 1980; Receptors for 1,25(OH)2-vitamin D3 enriched in cloned osteoblast-like rat osteogenic sarcoma cells. FEBS Lett 115: 139-142.
32. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
33. Quarto R, Mastrogiacomo M, Cancedda R, et al. 2001; Repair of large bone defects with the use of autologous bonemarrowstromal cells. N Engl JMed 344: 385-386.
34. Ross RJ, Rodriguez-Arnao J, Bentham J, Coakley JH. 1993; The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill. Intens Care Med 19(suppl 2): S54-57.
35. Sarugaser R, Lickorish D, Baksh D, et al. 2005; Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23: 220-229.
36. Schroeder TM, Jensen ED, Westendorf JJ. 2005; Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryol Today 75: 213-225.
37. Sumanasinghe RD, Osborne JA, Loboa EG. 2008; Mesenchymal stem cell-seeded collagen matrices for bone repair: effects of cyclic tensile strain, cell density, and media conditions on matrix contraction in vitro. J Biomed Mater Res A 88: 778-786.
38. ter Brugge PJ, Jansen JA. 2002; In vitro osteogenic differentiation of rat bone marrow cells subcultured with and without dexamethasone. Tissue Eng 8: 321-331.
39. Tou L, Quibria N, Alexander JM. 2003; Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7. Mol Cell Endocrinol 205: 121-129.
40. Troyer DL, Weiss ML. 2008; Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26: 591-599.
41. Walsh S, Jordan GR, Jefferiss C, et al. 2001; High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology (Oxf) 40: 74-83.
42. Wang HS, Hung SC, Peng ST, et al. 2004; Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22: 1330-1337.
43. Wang L, Lazebnik M, Detamore MS. 2009; Hyaline cartilage cells outperform mandibular condylar cartilage cells in a TMJ fibrocartilage tissue engineering application. Osteoarthr Cartilage 17(3): 346-353.
44. Wang L, Seshareddy K, Weiss ML, Detamore MS. 2008; Effect of initial seeding density on human umbilical cord mesenchymal stromal cells for fibrocartilage tissue engineering. Tissue Eng A 1-9 [Epub ahead of print].
45. Wu KH, Zhou B, Lu SH, et al. 2007; In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem 100: 608-616.1
46. Yoshimoto H, Shin YM, Terai H, Vacanti JP. 2003; A biodegradable1 nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 24: 2077-2082.
47. Yuan X, Arthur FTM, Yao K. 2002; In vitro degradation of poly(Llactic acid) fibers in phosphate buffered saline. J Appl Polym Sci 85: 936-943.
48. Zhang ZY, Teoh SH, Chong MS, et al. 2008; Superior osteogenic capacity for bone tissue engineering of fetal compared to perinatal and adult mesenchymal stem cells. Stem Cells 1-5 [Epub ahead of print].